Eric J.G. Sijbrands
About
Eric J.G. Sijbrands is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Eric J.G. Sijbrands has authored 276 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Surgery, 94 papers in Endocrinology, Diabetes and Metabolism and 79 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Eric J.G. Sijbrands's work include Lipoproteins and Cardiovascular Health (100 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (61 papers) and Cancer, Lipids, and Metabolism (31 papers). Eric J.G. Sijbrands is often cited by papers focused on Lipoproteins and Cardiovascular Health (100 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (61 papers) and Cancer, Lipids, and Metabolism (31 papers). Eric J.G. Sijbrands collaborates with scholars based in Netherlands, United States and United Kingdom. Eric J.G. Sijbrands's co-authors include John J.P. Kastelein, Mandy van Hoek, Abbas Dehghan, Joep C. Defesche, Albert Hofman, Jacqueline C.M. Witteman, Albert Wiegman, Arend F. L. Schinkel, Albert Hofman and Jessica Rodenburg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.
In The Last Decade
Eric J.G. Sijbrands
273 papers receiving 12.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Eric J.G. Sijbrands Netherlands | 59 | 5.1k | 3.1k | 3.1k | 2.0k | 1.5k | 276 | 12.5k | ||
| Raúl D. Santos Brazil | 48 | 5.9k 1.2× | 3.6k 1.2× | 3.5k 1.1× | 1.4k 0.7× | 1.6k 1.0× | 375 | 12.8k | ||
| Samia Mora United States | 63 | 5.7k 1.1× | 5.3k 1.7× | 4.5k 1.4× | 1.9k 1.0× | 1.7k 1.1× | 222 | 15.7k | ||
| John R. Guyton United States | 53 | 6.2k 1.2× | 3.3k 1.1× | 2.5k 0.8× | 1.7k 0.9× | 1.8k 1.1× | 166 | 12.0k | ||
| S. Matthijs Boekholdt Netherlands | 62 | 6.7k 1.3× | 5.4k 1.7× | 5.3k 1.7× | 1.5k 0.8× | 1.8k 1.2× | 293 | 14.5k | ||
| Eliot A. Brinton United States | 50 | 6.2k 1.2× | 5.7k 1.8× | 2.6k 0.9× | 1.3k 0.6× | 1.4k 0.9× | 153 | 12.1k | ||
| Jean MacFadyen United States | 42 | 8.1k 1.6× | 3.3k 1.0× | 4.1k 1.3× | 1.9k 1.0× | 1.5k 1.0× | 56 | 15.3k | ||
| Gloria Lena Vega United States | 61 | 4.7k 0.9× | 4.4k 1.4× | 2.9k 0.9× | 2.0k 1.0× | 1.4k 0.9× | 180 | 11.5k | ||
| Frank L.J. Visseren Netherlands | 59 | 4.6k 0.9× | 3.2k 1.0× | 5.9k 1.9× | 2.4k 1.2× | 1.2k 0.8× | 468 | 15.4k | ||
| Lâle Tokgözoğlu Türkiye | 42 | 6.3k 1.2× | 3.1k 1.0× | 4.6k 1.5× | 1.6k 0.8× | 1.6k 1.0× | 243 | 13.2k | ||
| Paul N. Hopkins United States | 63 | 5.0k 1.0× | 5.7k 1.8× | 5.3k 1.7× | 2.9k 1.4× | 1.1k 0.7× | 295 | 16.2k |
Countries citing papers authored by Eric J.G. Sijbrands
Since
Specialization
Citations
This map shows the geographic impact of Eric J.G. Sijbrands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J.G. Sijbrands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J.G. Sijbrands more than expected).
Fields of papers citing papers by Eric J.G. Sijbrands
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eric J.G. Sijbrands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J.G. Sijbrands. The network helps show where Eric J.G. Sijbrands may publish in the future.
Co-authorship network of co-authors of Eric J.G. Sijbrands
This figure shows the co-authorship network connecting the top 25 collaborators of Eric J.G. Sijbrands. A scholar is included among the top collaborators of Eric J.G. Sijbrands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric J.G. Sijbrands. Eric J.G. Sijbrands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hoedt, Sandra den, Simone M. Crivelli, Frank Leijten, et al.. (2024). The effects of APOE4 and familial Alzheimer's disease mutations on free fatty acid profiles in mouse brain are age‐ and sex‐dependent. Journal of Neurochemistry. 168(9). 3063–3075.
2.
Petrone, Marcella, et al.. (2024). Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model. British Journal of Pharmacology. 181(12). 1874–1885.
3.
Slieker, Roderick C., Simone Nicolardi, Joline W. J. Beulens, et al.. (2023). Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids. International Journal of Molecular Sciences. 24(19). 14844–14844.
4.
Wang, Kan, Fariba Ahmadizar, Banafsheh Arshi, et al.. (2023). Heart Rate Variability and Incident Type 2 Diabetes in General Population. The Journal of Clinical Endocrinology & Metabolism. 108(10). 2510–2516.
5.
Hoedt, Sandra den, Helga E. de Vries, Annemieke J.M. Rozemüller, et al.. (2023). Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline. Journal of Alzheimer s Disease Reports. 7(1). 339–354.
6.
Sijbrands, Eric J.G., et al.. (2023). Lipoprotein(a) is associated with a larger systemic burden of arterial calcification. European Heart Journal - Cardiovascular Imaging. 24(8). 1102–1109.
7.
Thoral, Patrick, Ronald H. Driessen, Eric J.G. Sijbrands, et al.. (2021). Sharing ICU Patient Data Responsibly Under the Society of Critical Care Medicine/European Society of Intensive Care Medicine Joint Data Science Collaboration: The Amsterdam University Medical Centers Database (AmsterdamUMCdb) Example*. Critical Care Medicine. 49(6). e563–e577.
8.
Vegt, Femmie de, Evertine J. Abbink, Femke Rutters, et al.. (2020). High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort. BMJ Open Diabetes Research & Care. 8(1). e000935–e000935.
9.
Herpt, Thijs T. W. van, et al.. (2020). Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study. Acta Diabetologica. 57(6). 725–732.
10.
Lieverse, Aloysius G., Florian Kronenberg, Claudia Lamina, et al.. (2020). Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus. Diabetologia. 63(6). 1248–1257.
11.
Liu, Jun, Sabina Semiz, Sven J. van der Lee, et al.. (2017). Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study. Metabolomics. 13(9). 104–104.
12.
Ligthart, Symen, Marjolein J. Peters, Joyce B. J. van Meurs, et al.. (2016). Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes. Diabetologia. 59(5). 998–1006.
13.
Baldeón, Lucy, Karin Weigelt, Harm de Wit, et al.. (2016). Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D. Diabetology & Metabolic Syndrome. 8(1). 6–6.
14.
Oord, Stijn C.H. van den, Zeynettin Akkus, Guillaume Renaud, et al.. (2014). Assessment of carotid atherosclerosis, intraplaque neovascularization, and plaque ulceration using quantitative contrast-enhanced ultrasound in asymptomatic patients with diabetes mellitus. European Heart Journal - Cardiovascular Imaging. 15(11). 1213–1218.
15.
Oord, Stijn C.H. van den, Zeynettin Akkus, Johan G. Bosch, et al.. (2014). Impact of gender on the density of intraplaque neovascularization: A quantitative contrast-enhanced ultrasound study. Atherosclerosis. 233(2). 461–466.
16.
Schram, Miranda T., Evertine J. Abbink, Wanda M. Admiraal, et al.. (2012). The Diabetes Pearl: Diabetes biobanking in The Netherlands. BMC Public Health. 12(1). 949–949.
17.
Lipton, Jonathan, et al.. (2011). Impact of an Alerting Clinical Decision Support System for Glucose Control on Protocol Compliance and Glycemic Control in the Intensive Cardiac Care Unit. Diabetes Technology & Therapeutics. 13(3). 343–349.
18.
Thompson, Gilbert R., Alberico L. Catapano, Samir Saheb, et al.. (2010). Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe. Current Opinion in Lipidology. 21(6). 492–498.
19.
Akdim, Fatima, Erik S.G. Stroes, Eric J.G. Sijbrands, et al.. (2010). Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy. Journal of the American College of Cardiology. 55(15). 1611–1618.
20.
Sijbrands, Eric J.G., et al.. (2009). Mortality Risk Prediction by an Insurance Company and Long-Term Follow-Up of 62,000 Men. PLoS ONE. 4(5). e5457–e5457.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Raúl D. Santos Breakdown of academic impact, for papers by Samia Mora Breakdown of academic impact, for papers by John R. Guyton Breakdown of academic impact, for papers by S. Matthijs Boekholdt Breakdown of academic impact, for papers by Eliot A. Brinton Breakdown of academic impact, for papers by Jean MacFadyen Breakdown of academic impact, for papers by Gloria Lena Vega Breakdown of academic impact, for papers by Frank L.J. Visseren Breakdown of academic impact, for papers by Lâle Tokgözoğlu Breakdown of academic impact, for papers by Paul N. Hopkins